• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟来90分钟总比不来好:肝血管肉瘤一例的MRI扫描鉴别诊断

Better 90 Minutes Late than Never: Differential Diagnosis on MRI Scanning in a Case of Hepatic Angiosarcoma.

作者信息

Albu Teodora Anca, Iacob Nicoleta

机构信息

Faculty of Physics, West University of Timisoara, 300223 Timisoara, Romania.

ScanExpert, 300627 Timisoara, Romania.

出版信息

Life (Basel). 2024 Jun 28;14(7):823. doi: 10.3390/life14070823.

DOI:10.3390/life14070823
PMID:39063577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11278181/
Abstract

Primary hepatic angiosarcoma (PHA) is a rare liver malignancy with few studies describing its radiological characteristics. This article aims to assess the imaging features of each of the multiple delayed contrast-enhanced magnetic resonance imaging (MRI) scans, in addition to the conventional MRI protocol, in a patient with PHA. Standard MRI sequences and a liver protocol were used in the examination of a 71 year-old male with pathologically proven PHA after current imaging evaluation. In addition, the patient underwent transversal and coronal MRI T1-weighted scans at 10 min, 20 min and 90 min after intravenous (IV) administration of gadobenatedimeglumine (Gd-BOPTA). The PHA revealed a variable appearance on MRI, with classic imaging being insufficient in making a reliable diagnosis. Lesions have increased vascularity, which translates into increased IV contrast uptake in the MRI arterial phase, showing progressive and globular enhancement in the portal and parenchymatous phases. On delayed scans, at 10 min after IV administration, the lesions maintained no washout, but slightly began to washout at 20 min post-contrast. However, in the hepatobiliary phase (90 min post-contrast injection), on an MRI T1-weighted sequence, PHA lesions were hypointense, suggesting the absence of hepatocytes, thus indicating high-grade malignancy. This approach proved the conclusion that in a patient with PHA, an extra MRI T1-weighted scan at 90 min post-gadobenatedimeglumine injection can provide helpful information in differential diagnosis.

摘要

原发性肝血管肉瘤(PHA)是一种罕见的肝脏恶性肿瘤,很少有研究描述其放射学特征。本文旨在评估一名PHA患者除传统MRI检查方案外,多次延迟对比增强磁共振成像(MRI)扫描的影像特征。在对一名经病理证实为PHA的71岁男性患者进行当前影像评估后,采用标准MRI序列和肝脏检查方案进行检查。此外,患者在静脉注射钆贝葡胺(Gd-BOPTA)后10分钟、20分钟和90分钟接受了横轴位和冠状位MRI T1加权扫描。PHA在MRI上表现多样,典型影像不足以做出可靠诊断。病变血管增多,这在MRI动脉期表现为静脉造影剂摄取增加,在门静脉期和实质期呈渐进性和球形强化。在延迟扫描中,静脉注射后10分钟,病变无廓清,但在造影剂注射后20分钟开始轻微廓清。然而,在肝胆期(造影剂注射后90分钟),在MRI T1加权序列上,PHA病变呈低信号,提示缺乏肝细胞,因此表明为高级别恶性肿瘤。该方法证实了以下结论:对于PHA患者,在注射钆贝葡胺后90分钟进行额外的MRI T1加权扫描可为鉴别诊断提供有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b0/11278181/0b0a581f92c0/life-14-00823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b0/11278181/e71a7aef999b/life-14-00823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b0/11278181/0b0a581f92c0/life-14-00823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b0/11278181/e71a7aef999b/life-14-00823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b0/11278181/0b0a581f92c0/life-14-00823-g002.jpg

相似文献

1
Better 90 Minutes Late than Never: Differential Diagnosis on MRI Scanning in a Case of Hepatic Angiosarcoma.迟来90分钟总比不来好:肝血管肉瘤一例的MRI扫描鉴别诊断
Life (Basel). 2024 Jun 28;14(7):823. doi: 10.3390/life14070823.
2
Gadolinium Magnetic Resonance Imaging钆磁共振成像
3
Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.肝脓肿。使用钆-双胺的磁共振成像表现
Invest Radiol. 1996 Dec;31(12):781-8. doi: 10.1097/00004424-199612000-00008.
4
Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.肝内肿块型胆管癌:钆贝葡胺增强磁共振成像(Gd-BOPTA-MRI)的强化模式,重点关注肝胆期。
Abdom Imaging. 2015 Oct;40(7):2313-22. doi: 10.1007/s00261-015-0445-5.
5
Detectability of small liver metastases with gadolinium BOPTA.钆布醇增强磁共振成像对小肝转移灶的可探测性
Invest Radiol. 1997 Sep;32(9):557-65. doi: 10.1097/00004424-199709000-00008.
6
Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria.新组织学标准定义的早期肝细胞癌的钆塞酸增强 MRI 表现。
J Magn Reson Imaging. 2012 Feb;35(2):393-8. doi: 10.1002/jmri.22828. Epub 2011 Oct 11.
7
[Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].肝脏局灶性病变的磁共振成像:钆对比剂与网状内皮肝细胞特异性对比剂的动态对比增强评估
Radiol Med. 2000 Oct;100(4):245-50.
8
[Analysis of MRI features of hepatocyte nuclear factor 1α-inactivated hepatocellular adenoma].肝细胞核因子1α失活型肝细胞腺瘤的MRI特征分析
Zhonghua Gan Zang Bing Za Zhi. 2023 Nov 20;31(11):1192-1197. doi: 10.3760/cma.j.cn501113-20220718-00386.
9
MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.MRI 对肝胆期良恶性肝细胞肿瘤的特征分析:同相位成像和病变肝脏视觉信号强度比的附加价值。
Eur Radiol. 2019 Nov;29(11):5742-5751. doi: 10.1007/s00330-019-06210-y. Epub 2019 Apr 16.
10
[Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].钆贝葡胺和钆喷酸葡胺在肝脏对比增强磁共振成像中的评估
Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):111-5.

引用本文的文献

1
Special Issue: "Novel Diagnosis and Treatment of Gastrointestinal Disease".特刊:“胃肠疾病的新型诊断与治疗”
Life (Basel). 2024 Dec 4;14(12):1603. doi: 10.3390/life14121603.

本文引用的文献

1
NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden.非酒精性脂肪性肝炎/非酒精性脂肪性肝病相关肝细胞癌:一项额外负担。
Life (Basel). 2023 Dec 23;14(1):25. doi: 10.3390/life14010025.
2
Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?肝硬化患者的门静脉血栓形成:出了什么问题?
Int J Gen Med. 2023 Aug 28;16:3889-3906. doi: 10.2147/IJGM.S413438. eCollection 2023.
3
Diffused primary hepatic angiosarcoma: a case description.弥漫性原发性肝血管肉瘤:病例描述
Quant Imaging Med Surg. 2023 Aug 1;13(8):5398-5402. doi: 10.21037/qims-23-219. Epub 2023 Jun 26.
4
Management Strategies and Outcomes in Primary Liver Angiosarcoma.原发性肝血管肉瘤的治疗策略及预后。
Am J Clin Oncol. 2023 Oct 1;46(10):439-444. doi: 10.1097/COC.0000000000001032. Epub 2023 Aug 15.
5
Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report.原发性肝血管肉瘤伴非肝硬化性门静脉高压症:一例报告。
Front Oncol. 2023 Feb 2;13:1037820. doi: 10.3389/fonc.2023.1037820. eCollection 2023.
6
Primary hepatic angiosarcoma: A case report.原发性肝血管肉瘤:一例报告。
World J Clin Cases. 2022 Nov 6;10(31):11590-11596. doi: 10.12998/wjcc.v10.i31.11590.
7
Hepatic angiosarcoma: Pitfalls in establishing a diagnosis.肝血管肉瘤:诊断中的陷阱。
SAGE Open Med Case Rep. 2021 Sep 17;9:2050313X211046726. doi: 10.1177/2050313X211046726. eCollection 2021.
8
Hepatobiliary phase hypointensity on gadobenate dimeglumine-enhanced magnetic resonance imaging may improve the diagnosis of hepatocellular carcinoma.钆布醇增强磁共振成像上的肝胆期低信号可能会改善肝细胞癌的诊断。
Ann Transl Med. 2021 Jan;9(1):55. doi: 10.21037/atm.2020.02.38.
9
Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI.钆塞酸增强MRI肝胆期的强化模式。
Br J Radiol. 2020 Aug;93(1112):20190989. doi: 10.1259/bjr.20190989. Epub 2020 Jun 1.
10
Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions.肝胆 MRI 对比剂:儿科局灶性肝脏病变的模式识别方法。
AJR Am J Roentgenol. 2020 May;214(5):976-986. doi: 10.2214/AJR.19.22239. Epub 2020 Mar 17.